human | Q5 |
P2671 | Google Knowledge Graph ID | /g/11fync39ph |
P6634 | LinkedIn personal profile ID | gail-daumit-50baa787 |
P2798 | Loop ID | 592673 |
P496 | ORCID iD | 0000-0003-0717-0216 |
P2038 | ResearchGate profile ID | Gail-Daumit |
P1153 | Scopus author ID | 6603941811 |
P4012 | Semantic Scholar author ID | 5189286 |
P2002 | X username | GailDaumit |
P27 | country of citizenship | United States of America | Q30 |
P69 | educated at | University of Pennsylvania | Q49117 |
Johns Hopkins Bloomberg School of Public Health | Q858206 | ||
Emory University School of Medicine | Q12241650 | ||
P108 | employer | Johns Hopkins Medicine | Q50363516 |
P734 | family name | Daumit | Q124003730 |
Daumit | Q124003730 | ||
Daumit | Q124003730 | ||
P735 | given name | Lois | Q3836481 |
Lois | Q3836481 | ||
Gail | Q19819754 | ||
Gail | Q19819754 | ||
P106 | occupation | professor | Q121594 |
epidemiologist | Q12765408 | ||
physician-scientist | Q25141651 | ||
P21 | sex or gender | female | Q6581072 |
Q94318341 | 27.2 COMPREHENSIVE CARDIOVASCULAR RISK REDUCTION TRIAL IN PERSONS WITH SERIOUS MENTAL ILLNESS |
Q94320166 | 6.4 TRIAL OF INTEGRATED TOBACCO SMOKING CESSATION, EXERCISE AND WEIGHT MANAGEMENT IN PERSONS WITH SERIOUS MENTAL ILLNESS |
Q55261414 | 8. DECREASING CARDIOVASCULAR RISK IN PERSONS WITH SCHIZOPHRENIA: INTERVENTIONS AND FUTURE DIRECTIONS. |
Q99637668 | A Model for Advancing Scale-Up of Complex Interventions for Vulnerable Populations: the ALACRITY Center for Health and Longevity in Mental Illness |
Q30542864 | A behavioral weight-loss intervention in persons with serious mental illness |
Q34455790 | A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls |
Q38842826 | A cost analysis of implementing a behavioral weight loss intervention in community mental health settings: Results from the ACHIEVE trial |
Q50797376 | A nutritional intervention to reduce the calorie content of meals served at psychiatric rehabilitation programs. |
Q82745230 | Adverse events during medical and surgical hospitalizations for persons with schizophrenia |
Q47557717 | An innovative model to coordinate healthcare and social services for people with serious mental illness: A mixed-methods case study of Maryland's Medicaid health home program |
Q37039179 | Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study |
Q89530382 | Association Between the Maryland Medicaid Behavioral Health Home Program and Cancer Screening in People With Serious Mental Illness |
Q101054500 | Behavioral health home impact on transitional care and readmissions among adults with serious mental illness |
Q59792277 | Bringing an Effective Behavioral Weight Loss Intervention for People With Serious Mental Illness to Scale |
Q37427364 | Cancer incidence in a sample of Maryland residents with serious mental illness |
Q40156016 | Cardiorespiratory benefits of group exercise among adults with serious mental illness. |
Q93141429 | Care Coordination and Population Health Management Strategies and Challenges in a Behavioral Health Home Model |
Q31145823 | Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1 |
Q51951599 | Characteristics of primary care visits for individuals with severe mental illness in a national sample. |
Q42348119 | Chronic pain and narcotics: a dilemma for primary care |
Q37190653 | Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial. |
Q36567074 | Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective |
Q47551464 | Comorbid Psychiatric Disease Is Associated With Lower Rates of Thrombolysis in Ischemic Stroke. |
Q33819180 | Comparative effectiveness of weight-loss interventions in clinical practice |
Q92262371 | Cost of behavioral weight loss programs implemented in clinical practice: The POWER trial at Johns Hopkins |
Q50782387 | Dietary intake of adults with serious mental illness. |
Q91594222 | Effect of a Behavioral Weight Loss Intervention in People With Serious Mental Illness and Diabetes |
Q96340291 | Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness: A Randomized Clinical Trial |
Q37710658 | Effectiveness of the Rigo Chêneau versus Boston-style orthoses for adolescent idiopathic scoliosis: a retrospective study |
Q90020028 | Effects of Maryland's Affordable Care Act Medicaid Health Home Waiver on Quality of Cardiovascular Care Among People with Serious Mental Illness |
Q92245820 | Effects of a behavioural weight loss intervention in people with serious mental illness: Subgroup analyses from the ACHIEVE trial |
Q46850368 | Erratum to “National estimates of adverse events during nonpsychiatric hospitalizations for persons with schizophrenia” [General Hospital Psychiatry 32 (2010) 419–425]. |
Q81332579 | Evaluation of "depression in primary care" innovations |
Q30379171 | Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. |
Q91896800 | From Stigma to Validation: A Qualitative Assessment of a Novel National Program to Improve Retention of Physician-Scientists with Caregiving Responsibilities |
Q36608497 | From efficacy to effectiveness: lessons learned from the Practice-Based Opportunities for Weight Reduction (POWER) trial |
Q92467522 | General Medical Clinicians' Attitudes Toward People with Serious Mental Illness: A Scoping Review |
Q37131022 | Guideline-concordant antipsychotic use and mortality in schizophrenia |
Q49103543 | Health Insurance Coverage Among Persons With Schizophrenia in the United States |
Q37075921 | Health status of individuals with serious mental illness |
Q36973177 | Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. |
Q54995835 | Implementation of a system-wide health promotion intervention to reduce early mortality in high risk adults with serious mental illness and obesity. |
Q37181364 | Increasing US health plan coverage for exercise programming in community mental health settings for people with serious mental illness: a position statement from the Society of Behavior Medicine and the American College of Sports Medicine |
Q40093701 | Informed and patient-centered decision-making in the primary care visits of African Americans with depression |
Q37292356 | Injury risk and severity in a sample of Maryland residents with serious mental illness |
Q96121632 | Integrating Mental Health and Addiction Treatment Into General Medical Care: The Role of Policy |
Q36377890 | Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review |
Q34400040 | Is serious mental illness associated with earlier death among persons with HIV? Ten year follow up in Maryland Medicaid Recipients |
Q34029603 | Longitudinal accuracy of web-based self-reported weights: results from the Hopkins POWER Trial |
Q52318450 | Measuring Variation Across Dimensions of Integrated Care: The Maryland Medicaid Health Home Model. |
Q47550225 | Mental Health Providers' Attitudes About Criminal Justice-Involved Clients With Serious Mental Illness |
Q34077459 | National estimates of adverse events during nonpsychiatric hospitalizations for persons with schizophrenia |
Q64244211 | Need for Cardiovascular Risk Reduction in Persons With Serious Mental Illness: Design of a Comprehensive Intervention |
Q51839698 | Obesity among those with mental disorders: a National Institute of Mental Health meeting report. |
Q35833662 | Opioid prescribing for chronic nonmalignant pain in primary care: challenges and solutions |
Q44330133 | Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. |
Q44309866 | Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States |
Q37307741 | Patient Safety Events and Harms During Medical and Surgical Hospitalizations for Persons With Serious Mental Illness |
Q38756380 | Patient, Provider, and System Factors Contributing to Patient Safety Events During Medical and Surgical Hospitalizations for Persons With Serious Mental Illness |
Q91751179 | Patients with stroke and psychiatric comorbidities have lower carotid revascularization rates |
Q34252921 | Pattern of mortality in a sample of Maryland residents with severe mental illness |
Q36989532 | Perceptions of strategies for successful weight loss in persons with serious mental illness participating in a behavioral weight loss intervention: A qualitative study. |
Q37186399 | Physical activity levels of persons with mental illness attending psychiatric rehabilitation programs. |
Q51925294 | Physical activity patterns in adults with severe mental illness. |
Q92042188 | Physical health outcomes and implementation of behavioural health homes: a comprehensive review |
Q36192034 | Post-myocardial-infarction quality of care among disabled Medicaid beneficiaries with and without serious mental illness |
Q51944911 | Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. |
Q44605750 | Prevalence of chronic obstructive pulmonary disease among those with serious mental illness |
Q57062061 | Prioritizing Safety Among Patients With Serious Mental Illness |
Q34629599 | Quality of care for heart failure among disabled Medicaid recipients with and without severe mental illness |
Q34577138 | Quality of clinical reports on behavioral interventions for hypertension |
Q27026165 | Quality of medical care for persons with serious mental illness: A comprehensive review |
Q37292361 | Racial patterns of cardiovascular disease risk factors in serious mental illness and the overall U.S. population |
Q34468141 | Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trial |
Q30597086 | Rationale, design and baseline data for the Activating Consumers to Exercise through Peer Support (ACE trial): A randomized controlled trial to increase fitness among adults with mental illness |
Q51955632 | Receipt of preventive medical services at psychiatric visits by patients with severe mental illness. |
Q36328104 | Recruitment and enrollment of African Americans and Caucasians in a health promotion trial for persons with serious mental illness |
Q26849474 | Review of the evidence: prevalence of medical conditions in the United States population with serious mental illness |
Q34564181 | Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study |
Q35222921 | Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence |
Q96307256 | Serious Mental Illness in Primary Care: a National Physician Survey |
Q93075692 | Smoking cessation in people with serious mental illness |
Q28289014 | Systematic review: the value of the periodic health evaluation |
Q38939152 | The Experience of Peer Mentors in an Intervention to Promote Smoking Cessation in Persons with Psychiatric Illness |
Q92200070 | The Most Valuable Resource Is Time: Insights From a Novel National Program to Improve Retention of Physician-Scientists With Caregiving Responsibilities |
Q90047056 | The Policy Ecology of Behavioral Health Homes: Case Study of Maryland's Medicaid Health Home Program |
Q92709067 | The effects of the Maryland Medicaid Health Home Waiver on Emergency Department and inpatient utilization among individuals with serious mental illness |
Q36689666 | The use of peer mentors to enhance a smoking cessation intervention for persons with serious mental illnesses |
Q51945327 | To whom do psychiatrists offer smoking-cessation counseling? |
Q50782292 | Use and costs of nonrecommended tests during routine preventive health exams. |
Q36879868 | Value of the periodic health evaluation. |
Q62587828 | Weight Loss in Persons with Serious Mental Illness |
Q35027859 | Willingness to pay for continued delivery of a lifestyle-based weight loss program: The Hopkins POWER trial. |
Search more.